Answers are grounded in this paper and cite their sources.
In this review the data of literature on the issue of polyclonality as a factor of resistance to antitumor treatment are given. Breast cancer is a heterogeneous disease and tumor typing is of paramount importance to achieve good clinical outcomes. Although it is common to stratify and treat breast tumors as a single entity, findings of intratumoral heterogeneity and cancer stem cell research raise the possibility that multiple breast cancer subtypes may coexist in a tumor. Plasticity plays a role in the dynamic transformation between breast cancer subtypes, the clinical implications of which will be the need for combination therapeutic strategies that take into account individual disease forms and their plasticity. Accordingly, improvements in single-cell sequencing technologies will be crucial for the diagnosis and stratification of individual disease subtypes down to the cellular level.
No takes yet. Share an insight, caveat, or question.
Loginova et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: